MedTrace Logo

Transcutaneous Electrical Nerve Stimulation for Early Pain Control in Temporomandibular Disorders

NCT07744893 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2026-08-04

No results posted yet for this study

Summary

To evaluate whether adding conventional transcutaneous electrical nerve stimulation (TENS) to a standard conservative regimen (patient education, pharmacotherapy, and a home exercise programme) provides additional short- and medium-term benefit for pain, mandibular function, and quality of life in patients with temporomandibular disorders (TMD).

Conditions

  • Temporomandibular Disorders (TMD)

Interventions

OTHER

Standard Conservative Therapy

Patient education about the resting position of the tongue and mandible and avoidance of parafunctional habits; a two-week pharmacological regimen of dexketoprofen 50 mg/day and thiocolchicoside 16 mg/day; and a standardised home exercise programme comprising active and passive jaw range-of-motion, isometric, and postural exercises

DEVICE

Transcutaneous Electrical Nerve Stimulation (TENS)

A charge-balanced biphasic waveform with a pulse width of 200 µs, a frequency of 100 Hz, and an amplitude adjusted to produce a comfortable, non-painful paraesthesia using an Intelect® TENS device. Sessions lasted 30 minutes and were applied 5 days per week for 2 weeks (10 sessions)

Sponsors & Collaborators

  • Necmettin Erbakan University

    collaborator OTHER

  • Balikesir University

    lead OTHER

Principal Investigators

  • Nilay Şahin, Prof. Dr. · Balikesir University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-01
Primary Completion
2013-05-01
Completion
2013-05-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07744893 on ClinicalTrials.gov